BRaIN Program Seminar Series Spring 2023
Wednesdays, 4 to 5 p.m.
CORE Seminar Series Spring 2023
CHHD Program Seminar Series Spring 2023
MeDiC Program Seminar Series Spring 2023
The first participants in this large study were recently selected at the Cedars Cancer Centre of the MUHC.
A passion to change the lives of cancer patients, young and old
Omani researcher Maha al-Riyami, PhD, studies underlying causes of type 1 diabetes and other autoimmune diseases
Marissa Fazio’s M.Sc. project aims to prevent health-care-associated...
A clearer understanding of how brain tumours originate during brain development is paving the way for improved therapies against pediatric high-grade gliomas, the leading cause of cancer-related...
Led by the Opal group at the RI-MUHC, the consortium has already made advances in data infrastructure and governance, as well as improving...
RI-MUHC researcher David P. Labbé and a team of international collaborators will investigate the mechanisms...
Dr. Thomas Hemmerling leads the development of an artificial intelligence-driven technology designed to...
RI-MUHC researcher aims to improve respiratory health of patients with lung infections
RI-MUHC researcher takes a leading role in several WHO initiatives
Trainees’ oral and poster presentations and a keynote lecture by Mark Andermann, PhD, were high points in the successful 2022 research event
Meakins-Christie and RESP Program Seminar Series Spring 2023
Dr. Phil Gold recently received the McGill Medal
A new grant from the Canada Foundation for Innovation will invest in leading edge Containment Level 3...